Open
鉅世以清除體內有害之死亡細胞為目標,研發SLE等疾病新藥,創辦人與團隊具有多年生物醫療經驗。
Our journey started in 2017. Back then we were a team of passionate biomedical researchers from academia, clinical, and pharmaceutical industry.
Our journey started in 2017. Back then we were a team of passionate biomedical researchers from academia, clinical, and pharmaceutical industry.